Most Recent Articles about ABT
CGM Devices Gain Steam, Set New Trend in Diabetes Management|industry_focus-527773 Sep 20, 2019 - The FDA authorization classifies the new type of CGM devices in class II and subjects these to certain criteria called special controls.
Abbott Receives European Nod for Pediatric Heart Devices|company_news_-_medical_sector-524246 Sep 18, 2019 - Abbott (ABT) aims to offer better treatment options for the most vulnerable patient population.
Abbott Partners With Sanofi to Upgrade Diabetes Management|company_news_-_medical_sector-522662 Sep 17, 2019 - Abbott (ABT) collaborates with Sanofi to revolutionize diabetes care through technological advancements.

Related Companies

Name Exchange Price Mkt Cap
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
LLY Eli Lilly and Company NYSE $105.71 $113.53B
SNY Sanofi NYSE $43.75 $109.14B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals